Skip to main content
Fig. 3 | Alzheimer's Research & Therapy

Fig. 3

From: Statins and cognitive decline in patients with Alzheimer’s and mixed dementia: a longitudinal registry-based cohort study

Fig. 3

Cognitive decline, evaluated with change in MMSE score over time, in statin users compared to non-users of statins. The graph shows the association between increasing doses of statin treatment and MMSE over time, as predicted from the model. Linear mixed-effects regression model, adjusted for demographic characteristics, comorbidities and comedication, with inverse probability weighting. DDD defined daily dose. DDD is defined by the World Health Organization as the assumed average maintenance daily dose of a medication for its primary indication in adults. Yearly visit 1 represent the first MMSE measurement (baseline)

Back to article page

Alzheimer's Research & Therapy

ISSN: 1758-9193